NanoGroup S.A.

Warsaw Stock Exchange NNG.WA

NanoGroup S.A. Price to Earnings Ratio (P/E) on January 14, 2025: -11.06

NanoGroup S.A. Price to Earnings Ratio (P/E) is -11.06 on January 14, 2025, a -272.23% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • NanoGroup S.A. 52-week high Price to Earnings Ratio (P/E) is -2.68 on February 13, 2024, which is 75.72% above the current Price to Earnings Ratio (P/E).
  • NanoGroup S.A. 52-week low Price to Earnings Ratio (P/E) is -13.31 on September 18, 2024, which is -20.37% below the current Price to Earnings Ratio (P/E).
  • NanoGroup S.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is -6.89.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Warsaw Stock Exchange: NNG.WA

NanoGroup S.A.

CEO Mr. Przemyslaw Daniel Mazurek
IPO Date March 14, 2018
Location Poland
Headquarters Rakowiecka 36
Employees 46
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.

StockViz Staff

January 15, 2025

Any question? Send us an email